Ranitidine Bismuth Citrate Patent Expiration
Ranitidine Bismuth Citrate is Used for treating gastrointestinal disorders caused by H. pylori and peptic ulcer disease caused by C. pyloridis through the administration of ranitidine bismuth citrate, clarithromycin, and bismuth. It was first introduced by Glaxosmithkline
Ranitidine Bismuth Citrate Patents
Given below is the list of patents protecting Ranitidine Bismuth Citrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tritec | US5629297 | Medicament for treating gastrointestinal disorders |
May 13, 2014
(Expired) | Glaxosmithkline |
| Tritec | US5601848 | Methods for the treatment of gastrointestinal disorders |
Feb 11, 2014
(Expired) | Glaxosmithkline |
| Tritec | US5456925 | Pharmaceutical compositions containing furan derivatives |
Oct 10, 2012
(Expired) | Glaxosmithkline |
Ranitidine Bismuth Citrate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List